AHP Logo


Latest News from AHP

Greg Fann Quoted in Atlanta Journal-Constitution on ACA Reinsurance Waiver Impact on Subsidized Enrollees

Consulting Actuary Greg Fann, FSA, FCA, MAAA was quoted in a recent Atlanta Journal-Constitution article on the implications of ACA reinsurance waivers for subsidized enrollees...

SOA Research Report: Reimagining Pharmacy Financing

Recently AHP consulting actuaries Joan Barrett, Tony Pistilli, Nathan Stokes, and Gregory Warren, teamed up to look into the total cost of care across medical & pharmacy. The focus was on two key drug classes where newer more expensive therapies promise better outcomes relative to older less expensive traditional treatments. "Prescription drug costs remain a critical concern for consumers, payers and policymakers alike. Despite legislative efforts, such as the Inflation Reduction Act, the challenge [...]

Joan Barrett and Tony Pistilli Co-author SOA Research Report

Have you wondered what are the chances you will lose more than $1 million if you make a specific decision?  If so, you may want to apply the concept of total risk analysis, a consistent, comprehensive framework, for analyzing the risk associated with projecting healthcare costs. This concept was recently introduced in the research report “Calculated Risk: Driving Decisions Using the 5/50 Research” co-authored by AHP consultants Joan Barrett and Tony Pistilli, along with [...]

Greg Warren Quoted in Insurance Business America Article

How are insurers coping with the increased demand for multi-use drugs like Wegovy and Ozempic? In an article by Insurance Business America, AHP Partner and Consulting Actuary, Greg Warren shares his insights from an actuarial perspective on the evolving pharmaceutical landscape and discuss the questions many plan sponsors are likely asking themselves when it comes to coverage of these drugs. Read Full Article

Greg Warren and Tony Pistilli Featured on Health Section SOA Podcast

AHP Partner and Consulting Actuary Greg Warren and Consulting Actuary Tony Pistilli were recently featured on the Health Section SOA Podcast to discuss their article on the Coming Wave of Biosimilars. This podcast and its related series of articles in Health Watch help actuaries better understand the potential clinical and financial impact the coming wave of biosimilars could have on our healthcare system and how plan sponsors can best leverage it for their populations. [...]

Go to Top